CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
(Senior) Research Associate - Immuno-Oncology (gn)
About us
iOmx Therapeutics is a clinical-stage company in the field of immuno-oncology located in Martinsried/Munich, Germany. We are focusing on the development of first-in-class cancer immunot...
